SLC41A3

gene
On this page

Also known as FLJ20473

Summary

SLC41A3 (solute carrier family 41 member 3, HGNC:31046) is a protein-coding gene on chromosome 3q21.2-q21.3, encoding Solute carrier family 41 member 3 (Q96GZ6). Na(+)/Mg(2+) ion exchanger that acts as a predominant Mg(2+) efflux system at the mitochondrial inner membrane.

Enables magnesium:sodium antiporter activity. Involved in mitochondrial magnesium ion transmembrane transport. Located in mitochondrial inner membrane and plasma membrane.

Source: NCBI Gene 54946 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 106 total
  • MANE Select transcript: NM_017836

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31046
Approved symbolSLC41A3
Namesolute carrier family 41 member 3
Location3q21.2-q21.3
Locus typegene with protein product
StatusApproved
AliasesFLJ20473
Ensembl geneENSG00000114544
Ensembl biotypeprotein_coding
OMIM610803
Entrez54946

Gene structure

Transcript identifiers

Ensembl transcripts: 36 — 29 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay

ENST00000315891, ENST00000346785, ENST00000360370, ENST00000383598, ENST00000504035, ENST00000504118, ENST00000505996, ENST00000506102, ENST00000507008, ENST00000507280, ENST00000508835, ENST00000509064, ENST00000509452, ENST00000510651, ENST00000512470, ENST00000512557, ENST00000513464, ENST00000513723, ENST00000514023, ENST00000514333, ENST00000514677, ENST00000514891, ENST00000910125, ENST00000910126, ENST00000910127, ENST00000910128, ENST00000910129, ENST00000910130, ENST00000910131, ENST00000947432, ENST00000947433, ENST00000947434, ENST00000947435, ENST00000947436, ENST00000947437, ENST00000947438

RefSeq mRNA: 5 — MANE Select: NM_017836 NM_001008485, NM_001008486, NM_001008487, NM_001164475, NM_017836

CCDS: CCDS33842, CCDS33843, CCDS33844, CCDS43144, CCDS54635

Canonical transcript exons

ENST00000360370 — 11 exons

ExonStartEnd
ENSE00001559606126084093126084124
ENSE00002084619126006357126007225
ENSE00003462142126015494126015573
ENSE00003478742126008732126008880
ENSE00003602380126012615126012749
ENSE00003642951126026335126026479
ENSE00003656958126022786126022932
ENSE00003671645126050943126051050
ENSE00003680006126067947126068246
ENSE00003685678126033607126033678
ENSE00003692093126016731126016875

Expression profiles

Bgee: expression breadth ubiquitous, 273 present calls, max score 96.17.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.1359 / max 87.0869, expressed in 1767 samples.

FANTOM5 promoters (9 alternative TSS)

Promoter IDTPM avgSamples expressed
443146.78131745
443161.90781085
443150.149130
443120.134848
443170.125170
443090.01533
443130.015210
443110.00442
443100.00302

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right hemisphere of cerebellumUBERON:001489096.17gold quality
cerebellar hemisphereUBERON:000224596.08gold quality
cerebellar cortexUBERON:000212996.05gold quality
descending thoracic aortaUBERON:000234595.14gold quality
cerebellumUBERON:000203795.13gold quality
left ovaryUBERON:000211995.07gold quality
prefrontal cortexUBERON:000045195.06gold quality
anterior cingulate cortexUBERON:000983595.06gold quality
cingulate cortexUBERON:000302795.02gold quality
right frontal lobeUBERON:000281094.97gold quality
right ovaryUBERON:000211894.80gold quality
thoracic aortaUBERON:000151594.72gold quality
ascending aortaUBERON:000149694.70gold quality
right testisUBERON:000453494.36gold quality
middle temporal gyrusUBERON:000277194.19gold quality
hindlimb stylopod muscleUBERON:000425294.19gold quality
left testisUBERON:000453394.13gold quality
cortical plateUBERON:000534394.11gold quality
body of uterusUBERON:000985394.01gold quality
aortaUBERON:000094793.99gold quality
right adrenal gland cortexUBERON:003582793.95gold quality
left adrenal glandUBERON:000123493.89gold quality
left adrenal gland cortexUBERON:003582593.86gold quality
right coronary arteryUBERON:000162593.68gold quality
amygdalaUBERON:000187693.68gold quality
adenohypophysisUBERON:000219693.64gold quality
right adrenal glandUBERON:000123393.62gold quality
neocortexUBERON:000195093.60gold quality
Brodmann (1909) area 9UBERON:001354093.60gold quality
popliteal arteryUBERON:000225093.55gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-4850no189.77
E-GEOD-99795no89.79
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

22 targeting SLC41A3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-651-3P99.9473.485177
HSA-MIR-338-5P99.9272.342951
HSA-MIR-1211999.8768.351653
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-1213099.7565.47452
HSA-MIR-4649-3P99.5666.901783
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-6814-5P99.0366.681273
HSA-MIR-6760-5P98.8766.731515
HSA-MIR-2467-3P98.6567.181969
HSA-MIR-6878-5P98.4967.912142
HSA-MIR-6864-5P98.3866.591079
HSA-MIR-6511B-5P97.9865.64823
HSA-MIR-6811-5P97.9864.96848
HSA-MIR-1212797.9366.67793
HSA-MIR-392097.7569.021168
HSA-MIR-425397.4865.11692
HSA-MIR-6862-5P97.4864.84713
HSA-MIR-509-3-5P97.2167.741517
HSA-MIR-509-5P97.2167.901512

Literature-anchored findings (GeneRIF, showing 2)

  • Data identify SLC41A3 as the first mammalian mitochondrial Mg(2+) efflux system, which greatly enhances the understanding of intracellular Mg(2+) homeostasis. (PMID:27302215)
  • SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. (PMID:34819993)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_rerioslc41a3ENSDARG00000061272
mus_musculusSlc41a3ENSMUSG00000030089
rattus_norvegicusSlc41a3ENSRNOG00000045821
drosophila_melanogasterCG33181FBGN0053181
caenorhabditis_elegansZK1053.6WBGENE00014201
caenorhabditis_elegansWBGENE00019504
caenorhabditis_elegansWBGENE00022682

Paralogs (2): SLC41A1 (ENSG00000133065), SLC41A2 (ENSG00000136052)

Protein

Protein identifiers

Solute carrier family 41 member 3Q96GZ6 (reviewed: Q96GZ6)

All UniProt accessions (11): D6R925, D6R9M9, D6R9S7, D6R9X6, D6RC02, D6RDB0, D6RDM3, D6RF72, D6RHE3, D6RJC0, Q96GZ6

UniProt curated annotations — full annotation on UniProt →

Function. Na(+)/Mg(2+) ion exchanger that acts as a predominant Mg(2+) efflux system at the mitochondrial inner membrane.

Subcellular location. Mitochondrion inner membrane.

Similarity. Belongs to the SLC41A transporter family.

Isoforms (9)

UniProt IDNamesCanonical?
Q96GZ6-11yes
Q96GZ6-22
Q96GZ6-33
Q96GZ6-44
Q96GZ6-55
Q96GZ6-66
Q96GZ6-77
Q96GZ6-88
Q96GZ6-99

RefSeq proteins (5): NP_001008485, NP_001008486, NP_001008487, NP_001157947, NP_060306* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006667SLC41_membr_domDomain
IPR036739SLC41_membr_dom_sfHomologous_superfamily
IPR045349SLC41A1-3Family

Pfam: PF01769

Catalyzed reactions (Rhea), 1 shown:

  • Mg(2+)(in) + 2 Na(+)(out) = Mg(2+)(out) + 2 Na(+)(in) (RHEA:66616)

UniProt features (30 total): transmembrane region 10, splice variant 10, sequence conflict 5, sequence variant 2, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96GZ6-F179.100.42

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 109 (showing top): GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_MAGNESIUM_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GOCC_MITOCHONDRIAL_ENVELOPE, chr3q21, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOCC_ORGANELLE_INNER_MEMBRANE, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, DODD_NASOPHARYNGEAL_CARCINOMA_DN

GO Biological Process (8): mitochondrial magnesium ion transmembrane transport (GO:0045016), monoatomic ion transport (GO:0006811), monoatomic cation transport (GO:0006812), magnesium ion transport (GO:0015693), metal ion transport (GO:0030001), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085), monoatomic cation transmembrane transport (GO:0098655)

GO Molecular Function (5): magnesium:sodium antiporter activity (GO:0061768), protein binding (GO:0005515), monoatomic cation transmembrane transporter activity (GO:0008324), magnesium ion transmembrane transporter activity (GO:0015095), obsolete inorganic cation transmembrane transporter activity (GO:0022890)

GO Cellular Component (4): mitochondrial inner membrane (GO:0005743), plasma membrane (GO:0005886), mitochondrion (GO:0005739), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
magnesium ion transmembrane transport2
transport2
monoatomic cation transport2
monoatomic cation transmembrane transport2
monoatomic ion transport1
metal ion transport1
sodium ion transport1
cellular process1
monoatomic ion transmembrane transport1
sodium ion transmembrane transporter activity1
magnesium ion transmembrane transporter activity1
metal cation:monoatomic cation antiporter activity1
binding1
monoatomic ion transmembrane transporter activity1
metal ion transmembrane transporter activity1
organelle inner membrane1
mitochondrial membrane1
membrane1
cell periphery1
cytoplasm1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

540 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC41A3TRPM6Q9BX84791
SLC41A3MRS2Q9HD23695
SLC41A3CNNM2Q9H8M5688
SLC41A3TRPM7Q96QT4679
SLC41A3SPRYD7Q5W111600
SLC41A3MAGT1Q9H0U3597
SLC41A3MMGT1Q8N4V1519
SLC41A3CNNM3Q8NE01515
SLC41A3CNNM1Q9NRU3515
SLC41A3CLDN16Q9Y5I7512
SLC41A3CNNM4Q6P4Q7512
SLC41A3FXYD2P54710504
SLC41A3NIPAL3Q6P499498
SLC41A3SLC12A3P55017492
SLC41A3CLDN19Q8N6F1490

IntAct

53 interactions, top by confidence:

ABTypeScore
SLC41A3RELpsi-mi:“MI:0915”(physical association)0.560
NHERF4SLC41A3psi-mi:“MI:0915”(physical association)0.560
RELSLC41A3psi-mi:“MI:0915”(physical association)0.560
SLC41A3NHERF4psi-mi:“MI:0915”(physical association)0.560
SLC41A3SUFUpsi-mi:“MI:0915”(physical association)0.560
CCL3L1SLC41A3psi-mi:“MI:0915”(physical association)0.560
ARLNSLC41A3psi-mi:“MI:0915”(physical association)0.560
TMBIM6SLC41A3psi-mi:“MI:0915”(physical association)0.560
IGFBP5SLC41A3psi-mi:“MI:0915”(physical association)0.560
SLC41A3SMCO4psi-mi:“MI:0915”(physical association)0.560
PLP1SLC41A3psi-mi:“MI:0915”(physical association)0.560
TSPO2SLC41A3psi-mi:“MI:0915”(physical association)0.560
SLC41A3BDNFpsi-mi:“MI:0915”(physical association)0.560
GAPDHSLC41A3psi-mi:“MI:0915”(physical association)0.560
SLC41A3CCR2psi-mi:“MI:0915”(physical association)0.370
SLC41A3GPR37psi-mi:“MI:0915”(physical association)0.370
SLC41A3NPSR1psi-mi:“MI:0915”(physical association)0.370
SLC41A3SMOpsi-mi:“MI:0915”(physical association)0.370
MAPK6SLC41A3psi-mi:“MI:0915”(physical association)0.370
SLC41A3CREB3psi-mi:“MI:0915”(physical association)0.370
ZDHHC12NBASpsi-mi:“MI:0914”(association)0.350
ZACNFAM234Bpsi-mi:“MI:0914”(association)0.350
HTR3AEXTL3psi-mi:“MI:0914”(association)0.350
OR13J1FZD7psi-mi:“MI:0914”(association)0.350

BioGRID (104): SLC41A3 (Two-hybrid), PDZD3 (Two-hybrid), SLC41A3 (Affinity Capture-MS), SLC41A3 (Reconstituted Complex), SLC41A3 (Two-hybrid), SLC41A3 (Affinity Capture-MS), SLC41A3 (Affinity Capture-MS), SLC41A3 (Affinity Capture-MS), SLC41A3 (Affinity Capture-MS), SLC41A3 (Affinity Capture-RNA), SLC41A3 (Proximity Label-MS), SLC41A3 (Two-hybrid), SLC41A3 (Two-hybrid), IGFBP5 (Two-hybrid), PLP1 (Two-hybrid)

ESM2 similar proteins: A0A075B734, A1L272, A2IBY8, A8W649, A9Y006, D4A7H1, E7EXX2, F7B113, O14520, O35454, O54794, O62735, O94956, P34080, P35525, P41181, P47862, P47863, P47864, P51789, P51797, P56402, P56403, P79099, Q06495, Q06496, Q08DE6, Q4R691, Q5PQL3, Q62052, Q866S3, Q8BLV3, Q8BXB6, Q8BZ00, Q8IVB4, Q8K078, Q8MIQ9, Q8R2N1, Q8TCT8, Q921R8

Diamond homologs: E7EXX2, Q3SWT5, Q4R335, Q5R839, Q5ZHX6, Q6DFC0, Q8BJA2, Q8BYR8, Q8IVJ1, Q921R8, Q96GZ6, Q96JW4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

106 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance64
Likely benign7
Benign14

Top pathogenic / likely-pathogenic (0)

SpliceAI

1705 predictions. Top by Δscore:

VariantEffectΔscore
3:126008726:GCTTA:Gdonor_gain1.0000
3:126008727:CTTAC:Cdonor_gain1.0000
3:126008728:TTAC:Tdonor_loss1.0000
3:126008728:TTACC:Tdonor_gain1.0000
3:126008729:TA:Tdonor_loss1.0000
3:126008729:TACCT:Tdonor_gain1.0000
3:126008730:A:ACdonor_gain1.0000
3:126008730:A:Cdonor_gain1.0000
3:126008730:ACC:Adonor_loss1.0000
3:126008731:C:CCdonor_gain1.0000
3:126008731:C:Tdonor_gain1.0000
3:126008731:CCT:Cdonor_loss1.0000
3:126008876:GATTT:Gacceptor_gain1.0000
3:126008877:ATTT:Aacceptor_gain1.0000
3:126008878:TTT:Tacceptor_gain1.0000
3:126008879:TT:Tacceptor_gain1.0000
3:126008881:C:CCacceptor_gain1.0000
3:126008881:CTGAA:Cacceptor_loss1.0000
3:126008882:T:Cacceptor_loss1.0000
3:126015488:ACGT:Adonor_loss1.0000
3:126015491:TA:Tdonor_loss1.0000
3:126015492:A:ATdonor_loss1.0000
3:126015493:C:CAdonor_loss1.0000
3:126015493:CCA:Cdonor_gain1.0000
3:126015569:CGAAA:Cacceptor_gain1.0000
3:126015574:C:CCacceptor_gain1.0000
3:126016726:CTCA:Cdonor_loss1.0000
3:126016727:TCAC:Tdonor_loss1.0000
3:126016728:CACC:Cdonor_loss1.0000
3:126016729:A:Tdonor_loss1.0000

AlphaMissense

3122 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:126012713:C:GR336P0.997
3:126012715:G:CS335R0.995
3:126012715:G:TS335R0.995
3:126012717:T:GS335R0.995
3:126022850:G:CS227R0.994
3:126022850:G:TS227R0.994
3:126022852:T:GS227R0.994
3:126026372:G:CS187R0.990
3:126026372:G:TS187R0.990
3:126026374:T:GS187R0.990
3:126012704:G:AT339I0.989
3:126022842:T:GD230A0.989
3:126026369:A:CS188R0.989
3:126026369:A:TS188R0.989
3:126026371:T:GS188R0.989
3:126022808:G:CS241R0.988
3:126022808:G:TS241R0.988
3:126022810:T:GS241R0.988
3:126050953:A:GL124P0.988
3:126012698:A:GL341P0.987
3:126016765:A:GW286R0.987
3:126016765:A:TW286R0.987
3:126016733:G:CS296R0.986
3:126016733:G:TS296R0.986
3:126016735:T:GS296R0.986
3:126022842:T:CD230G0.985
3:126022879:C:GD218H0.984
3:126022842:T:AD230V0.983
3:126026473:C:GA154P0.983
3:126007180:A:GW434R0.982

dbSNP variants (sampled 300 via entrez): RS1000052601 (3:126092324 C>T), RS1000083037 (3:126021324 G>A), RS1000171506 (3:126067531 C>T), RS1000232780 (3:126072042 T>C), RS1000243563 (3:126024184 A>G), RS1000250942 (3:126071695 A>T), RS1000282866 (3:126043913 G>A), RS1000430825 (3:126037614 T>C), RS1000436309 (3:126096466 C>T), RS1000448016 (3:126009252 G>A,T), RS1000483174 (3:126037380 T>C), RS1000522615 (3:126076935 C>T), RS1000532158 (3:126054926 C>T), RS1000533635 (3:126096829 T>G), RS1000641052 (3:126096672 C>T)

Disease associations

OMIM: gene MIM:610803 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST011354_15Bell’s palsy3.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC41 family of divalent cation transporters

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation2
Aflatoxin B1decreases expression, increases methylation2
aristolochic acid Idecreases expression1
FR900359decreases phosphorylation1
bisphenol Faffects cotreatment, increases expression1
potassium perchloratedecreases expression1
sodium arseniteincreases abundance, increases expression1
di-n-butylphosphoric acidaffects expression1
bisphenol Saffects cotreatment, increases expression1
(+)-JQ1 compounddecreases expression1
Resveratroldecreases expression1
Arsenic Trioxidedecreases expression1
Arsenicincreases expression, increases abundance1
Caffeinedecreases phosphorylation1
Dexamethasoneaffects cotreatment, increases expression1
Indomethacinaffects cotreatment, increases expression1
Smokedecreases expression1
Tretinoinincreases expression1
Valproic Aciddecreases expression1
Zearalenonedecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Cyclosporineincreases methylation1
Antirheumatic Agentsincreases expression1
Cadmium Chlorideincreases expression1
Okadaic Aciddecreases expression1

Cellosaurus cell lines

5 cell lines: 4 cancer cell line, 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B3HIAbcam HEK293T SLC41A3 KOTransformed cell lineFemale
CVCL_D4P0HCT116-SLC41A3-KO-c10Cancer cell lineMale
CVCL_D4P1HCT116-SLC41A3-KO-c6Cancer cell lineMale
CVCL_TN68HAP1 SLC41A3 (-) 1Cancer cell lineMale
CVCL_TN69HAP1 SLC41A3 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Bell’s palsy